QT Imaging Holdings Inc
QT Imaging Holdings Inc develops and commercializes advanced medical imaging equipment, primarily serving diagnostic and therapeutic applications in the healthcare sector.
Business. QT Imaging Holdings Inc (QTI.O) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Qt Imaging Holdings Inc (QTI.O) has recorded its first institutional analysis, marking the initial baseline for tracking ownership activity. This inaugural review highlights the emergence of four new notable holders as of March 31, 2026, signaling early institutional interest in the company’s equity. The most significant addition among these new investors holds 19,325 shares, valued at approximately $0.11 million, representing a portfolio weight of roughly 0.0015%. This position stands out as the largest single entry among the newly identified stakeholders, suggesting a focused allocation despite the modest absolute value. Other notable additions include an investor holding 5,556 shares (valued at $0.03 million), another with 3,002 shares (valued at $0.02 million), and a fourth holding 1,594 shares (valued at $0.01 million). Collectively, these four entities now constitute the entirety of the company’s top five holder count, indicating a concentrated but nascent institutional base. With no prior analyst coverage or index membership recorded, these new holdings provide the first tangible data points for assessing market sentiment toward Qt Imaging. The absence of prior delta computation means these positions establish the initial reference frame for future ownership trends and potential liquidity developments.
Signals & dispatch
Composite-score breakdown
Synthesis
QT Imaging Holdings Inc (QTI.O) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
QT Imaging operates with a market capitalization of $84.3 million and a price-to-book ratio of 13.08, indicating a premium valuation relative to its equity base. The company's liquidity position is characterized by a current ratio of 2.81, suggesting adequate short-term liquidity, but its operating cash flow of -$8.96 million and free cash flow of -$21.08 million highlight significant cash outflows. The debt-to-equity ratio of 0.71 reflects a moderate leverage profile, with long-term debt of $4.59 million against total equity of $6.45 million.
Profitability metrics are underperforming relative to industry norms. The company reported a net loss of $21.08 million and an operating loss of $4.44 million, resulting in a negative return on equity of -3.27% and a return on assets of -0.92%. These figures fall below the typical performance of peers in the Advanced Medical Equipment & Technology industry, which emphasizes high R&D investment and long-term value creation.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to market-specific risks, particularly in the healthcare equipment sector, which is sensitive to regulatory and reimbursement changes.
Looking ahead, the company is projected to face continued financial pressure. Revenue is expected to remain flat or decline in the current fiscal year, with no significant growth anticipated in the next fiscal year. The negative operating and free cash flows suggest a lack of internal funding for expansion or R&D, which is critical in a capital-intensive industry.
The risk assessment highlights liquidity as a medium concern, with negative net cash after subtracting total debt. While dilution risk is currently low, the company's negative earnings and cash flows could necessitate future equity raises, potentially diluting existing shareholders. No recent filings or transcripts indicate material changes in the company's strategic direction or financial outlook.
Analysts have assigned a mean price target of $11.60, with a strong buy recommendation, but the absence of buy or hold ratings suggests limited consensus on the company's near-term prospects. The discrepancy between analyst optimism and the company's financial performance warrants close monitoring of upcoming earnings and capital-raising activities.
Qt Imaging Holdings Inc (QTI.O) has recorded its first institutional analysis, marking the initial baseline for tracking ownership activity. This inaugural review highlights the emergence of four new notable holders as of March 31, 2026, signaling early institutional interest in the company’s equity. The most significant addition among these new investors holds 19,325 shares, valued at approximately $0.11 million, representing a portfolio weight of roughly 0.0015%. This position stands out as the largest single entry among the newly identified stakeholders, suggesting a focused allocation despite the modest absolute value. Other notable additions include an investor holding 5,556 shares (valued at $0.03 million), another with 3,002 shares (valued at $0.02 million), and a fourth holding 1,594 shares (valued at $0.01 million). Collectively, these four entities now constitute the entirety of the company’s top five holder count, indicating a concentrated but nascent institutional base. With no prior analyst coverage or index membership recorded, these new holdings provide the first tangible data points for assessing market sentiment toward Qt Imaging. The absence of prior delta computation means these positions establish the initial reference frame for future ownership trends and potential liquidity developments.
- QT Imaging is trading at a premium to book value despite reporting a net loss and negative cash flows.
- The company's liquidity position is adequate in the short term but is challenged by ongoing negative operating cash flows.
- Profitability metrics are significantly below industry norms, with a negative return on equity and assets.
- Revenue concentration and lack of geographic diversification increase exposure to sector-specific risks.
- Analysts are optimistic about the stock, but the lack of consensus and financial underperformance suggest caution.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,11 |
| Revenue | —no estimate | —no estimate | 38,6M USD |
| Operating income | —no estimate | —no estimate | 340,000 USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Stock Option (right to buy) → Common StockDisposed 8 888 @ $2,25exercise · 2026-03-17
- Director · Stock Option (right to buy) → Common StockDisposed 14 166 @ $2,00exercise · 2026-03-17
- Director, CHAIRMAN · PRIVATE WARRANT → COMMON STOCKAcquired 48 214 @ $6,43purchase · 2026-01-22
- Director · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
- Director · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
- Director, 10% owner · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
- Director, Chairman · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
- Director · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
- Director, Chief Executive Officer · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
- Director · Stock Option (right to buy) → Common StockAcquired 25 000 @ $1,90grant · 2025-08-11
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- QT Imaging Holdings Inc Market data — financials · 2026-05-29
- QT Imaging Holdings Inc Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Director, Chairman · Common StockOther 3 500 · 2026-03-20
- Director · Common StockOther 3 500 · 2026-03-20
- Director · Common StockOther 3 500 · 2026-03-20
- Director · Common StockOther 3 500 · 2026-03-20
- Chief Financial Officer · Common StockOther 2 800 · 2026-03-20
- Director · Common StockOther 3 500 · 2026-03-20
- Director, 10% owner · Common StockOther 3 500 · 2026-03-20
- Director, Chief Executive Officer · Common StockOther 3 500 · 2026-03-20
- Director, Chief Executive Officer · Common StockOther 500 000 · 2026-03-20
- Director, Chief Executive Officer · Common StockOther 16 000 · 2026-03-20
- Director · Common StockOther 8 888 @ $2,25$20K · 2026-03-17
- Director · Common StockOther 14 166 @ $2,00$28K · 2026-03-17
- Director, CHAIRMAN · COMMON STOCKBought 24 107 @ $6,43$155K · 2026-01-22
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 1.8%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 788.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 6.1%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 278.2%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 63.6%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 5.6%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 167.6%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 225.2%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 361.9%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 10.7%Derived (calculated)
- Net margin (FY 2025-12-31): -111.4%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 2.57xDerived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 20.5%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.81xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 40.9%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 287.9%Derived (calculated)
- Return on equity (FY 2025-12-31): -327.1%Derived (calculated)
- Return on assets (FY 2025-12-31): -91.6%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -134.6%Derived (calculated)
- Gross margin (FY 2025-12-31): 45.4%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 5.6%Derived (calculated)
- Shareholders' equity (annual): USD 6.45MSEC XBRL filing
- Net income (annual): USD -21.08MSEC XBRL filing
- Gross profit (annual): USD 8.58MSEC XBRL filing